Fintel reports that on September 8, 2025, Oppenheimer upgraded their outlook for Boston Scientific (WBAG:BSXC) from Perform to Outperform.

Analyst Price Forecast Suggests 21.10% Upside

As of August 22, 2025, the average one-year price target for Boston Scientific is € 107,05/share. The forecasts range from a low of € 86,94 to a high of € 125,03. The average price target represents an increase of 21.10% from its latest reported closing price of € 88,40 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Boston Scientific is 15,839MM, a decrease of 14.36%. The projected annual non-GAAP EPS is 2.41.

What is the Fund Sentiment?

There are 2,817 funds or institutions reporting positions in Boston Scientific. This is an increase of 194 owner(s) or 7.40% in the last quarter. Average portfolio weight of all funds dedicated to BSXC is 0.57%, an increase of 5.88%. Total shares owned by institutions increased in the last three months by 0.09% to 1,533,083K shares.

What are Other Shareholders Doing?

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 47,576K shares representing 3.21% ownership of the company. In its prior filing, the firm reported owning 46,630K shares , representing an increase of 1.99%. The firm decreased its portfolio allocation in BSXC by 3.08% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 41,994K shares representing 2.84% ownership of the company. In its prior filing, the firm reported owning 40,952K shares , representing an increase of 2.48%. The firm decreased its portfolio allocation in BSXC by 3.00% over the last quarter.

Primecap Management holds 34,663K shares representing 2.34% ownership of the company. In its prior filing, the firm reported owning 36,497K shares , representing a decrease of 5.29%. The firm decreased its portfolio allocation in BSXC by 3.07% over the last quarter.

Bank Of America holds 33,845K shares representing 2.29% ownership of the company. In its prior filing, the firm reported owning 31,557K shares , representing an increase of 6.76%. The firm decreased its portfolio allocation in BSXC by 74.27% over the last quarter.

Wellington Management Group Llp holds 32,649K shares representing 2.21% ownership of the company. In its prior filing, the firm reported owning 33,198K shares , representing a decrease of 1.68%. The firm decreased its portfolio allocation in BSXC by 86.14% over the last quarter.